Old Web
English
Sign In
Acemap
>
authorDetail
>
Heidi Ott
Heidi Ott
Johnson & Johnson Pharmaceutical Research and Development
Biochemistry
Enzyme inhibitor
Tyrosine kinase
Organic chemistry
Chemistry
3
Papers
91
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
4-Amino-6-piperazin-1-yl-pyrimidine-5-carbaldehyde oximes as potent FLT-3 inhibitors.
2007
Bioorganic & Medicinal Chemistry Letters
Micheal D. Gaul
Guozhang Xu
Jennifer Kirkpatrick
Heidi Ott
Christian Andrew Baumann
Show All
Source
Cite
Save
Citations (14)
Identification of 2-acylaminothiophene-3-carboxamides as potent inhibitors of FLT3
2006
Bioorganic & Medicinal Chemistry Letters
Raymond J. Patch
Christian Andrew Baumann
Jian Liu
Alan C. Gibbs
Heidi Ott
Jennifer Lattanze
Mark R. Player
Show All
Source
Cite
Save
Citations (27)
2-Hydroxy-4,6-diamino-[1,3,5]triazines: A Novel Class of VEGF-R2 (KDR) Tyrosine Kinase Inhibitors
2005
Journal of Medicinal Chemistry
Nand Baindur
Naresh Chadha
Benjamin M. Brandt
Davoud Asgari
Raymond J. Patch
Céline Schalk-Hihi
Theodore E. Carver
Ioanna Petrounia
Christian Andrew Baumann
Heidi Ott
Carl L. Manthey
Barry A. Springer
Mark R. Player
Show All
Source
Cite
Save
Citations (50)
1